Cipandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Usage

1. Confirm the ampoule is within its printed expiry date and that the glass-fusion seal is fully intact — a quality feature Balkan Pharmaceuticals has maintained since the company's GMP certification.
2. Warm the ampoule briefly in your palm for 30–60 seconds to reduce the viscosity of the oil vehicle, easing aspiration into the syringe.
3. Score and snap the ampoule neck cleanly; draw the full 1 ml using an 18–21 gauge drawing needle to minimise particulate introduction.
4. Switch to a fresh 23–25 gauge, 1–1.5 inch injection needle for administration into the gluteus medius or vastus lateralis — the intramuscular sites used in clinical Depo-Testosterone protocols since the compound's clinical introduction.
5. Aspirate briefly, inject at a slow, steady pace (approximately 1 ml over 20–30 seconds), then withdraw and apply gentle pressure with a sterile swab.
6. Discard the used ampoule and needle immediately in an approved sharps container; rotate injection sites each session to reflect best practices derived from decades of clinical testosterone administration.

Warnings

Frequently asked questions

Where did Testosterone Cypionate originally come from and who developed it?

Testosterone Cypionate was developed by Upjohn Pharmaceuticals in the United States and launched commercially as Depo-Testosterone in 1951. It was among the first esterified androgens engineered specifically for long-acting intramuscular depot delivery. The US remains the primary market where it has held continuous FDA-approved status, distinguishing it historically from testosterone enanthate, which was developed in parallel within European pharmaceutical research.

How has the clinical use of Testosterone Cypionate evolved since the 1950s?

Initially prescribed for hypogonadism, delayed puberty, and certain breast cancers, Testosterone Cypionate's use expanded through the 1970s as sports medicine and performance physiology research grew. By the late 20th century it became a cornerstone of hormone replacement therapy (HRT) protocols, and contemporary prescribing guidelines from bodies such as the Endocrine Society still reference 200 mg per injection as a standard therapeutic interval dose.

Why did Testosterone Cypionate become more popular in North America than testosterone enanthate?

Testosterone Cypionate gained dominance in North America primarily because Upjohn's Depo-Testosterone was locally manufactured, widely distributed, and supported by decades of US clinical data. The one-carbon ester difference between cypionate and enanthate produces negligible practical distinction in most protocols, but regional prescribing habits, supply chains, and formulary listings established cypionate as the default American androgen reference standard — a position it has maintained to the present day.

Why does Cipandrol come in individual 1 ml ampoules rather than a multi-dose vial?

Single-dose ampoules eliminate the contamination risk that accumulates each time a needle punctures a rubber septum on a multi-dose vial. Glass-fusion sealed ampoules maintain container-closure integrity from the point of fill to the moment of use, a standard aligned with EU GMP Annex 1 requirements for parenteral products. Each of the 10 ampoules in a Cipandrol box is therefore sterile by design, with no dependency on preservatives or aseptic multi-draw technique.

What is the significance of the 200 mg/ml concentration, and how should Cipandrol ampoules be stored?

At 200 mg/ml, Cipandrol is the lower-concentration option within pharmaceutical testosterone cypionate offerings, making volume-based dose measurement more precise for users targeting the 200 mg clinical reference dose — one full 1 ml ampoule equals one standard therapeutic injection. Ampoules should be stored at 15–25 °C, protected from direct light, and kept in the original carton to prevent UV degradation of the oil vehicle. Opened ampoules must be used immediately and any remainder discarded. (2) angle_used

Manufacturer

Balkan Pharmaceuticals' quality infrastructure is structured around a dual certification framework: GMP (Good Manufacturing Practice) compliance for its Chișinău production facility and ISO-aligned quality management systems that govern raw-material intake, in-process controls, and finished-product release. For Cipandrol specifically, the certification framework mandates that each batch of Testosterone Cypionate 200 mg/ml passes through validated analytical checkpoints — HPLC for active-ingredient quantification and LAL (Limulus Amebocyte Lysate) testing for endotoxin detection — before any ampoule is released to the supply chain. GMP Annex 1 requirements for aseptic injectable manufacture define the environmental monitoring programme, clean-room classification, and container-closure integrity validation applied at the filling-and-closing stage. The company's certifications are not static credentials; they require periodic re-audit by competent authorities, a process that obliges continuous investment in personnel training, equipment qualification, and documentation control across the Chișinău site.